CA2633489C - Compositions et procedes pour le traitement de conditions dermatologiques - Google Patents

Compositions et procedes pour le traitement de conditions dermatologiques Download PDF

Info

Publication number
CA2633489C
CA2633489C CA2633489A CA2633489A CA2633489C CA 2633489 C CA2633489 C CA 2633489C CA 2633489 A CA2633489 A CA 2633489A CA 2633489 A CA2633489 A CA 2633489A CA 2633489 C CA2633489 C CA 2633489C
Authority
CA
Canada
Prior art keywords
formulation
volatile solvent
skin
drug
solvent system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2633489A
Other languages
English (en)
Other versions
CA2633489A1 (fr
Inventor
Jie Zhang
Kevin S. Warner
Sanjay Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvo Research Inc
Original Assignee
Nuvo Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvo Research Inc filed Critical Nuvo Research Inc
Publication of CA2633489A1 publication Critical patent/CA2633489A1/fr
Application granted granted Critical
Publication of CA2633489C publication Critical patent/CA2633489C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2633489A 2005-12-14 2006-12-14 Compositions et procedes pour le traitement de conditions dermatologiques Expired - Fee Related CA2633489C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US75052205P 2005-12-14 2005-12-14
US75046505P 2005-12-14 2005-12-14
US75052405P 2005-12-14 2005-12-14
US75063705P 2005-12-14 2005-12-14
US60/750,522 2005-12-14
US60/750,524 2005-12-14
US60/750,465 2005-12-14
US60/750,637 2005-12-14
PCT/US2006/047747 WO2007070643A2 (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement de conditions dermatologiques

Publications (2)

Publication Number Publication Date
CA2633489A1 CA2633489A1 (fr) 2007-06-21
CA2633489C true CA2633489C (fr) 2013-09-24

Family

ID=38163526

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2633489A Expired - Fee Related CA2633489C (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement de conditions dermatologiques

Country Status (6)

Country Link
EP (1) EP1959929A4 (fr)
JP (1) JP2009519940A (fr)
CN (1) CN101378729B (fr)
AU (1) AU2006326388B2 (fr)
CA (1) CA2633489C (fr)
WO (1) WO2007070643A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
ES2407407T3 (es) 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
CA2730787A1 (fr) * 2008-07-16 2010-01-21 David M. Cohen Systeme d'apport de medicament topique
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
MX2011003568A (es) * 2008-10-03 2011-06-09 Nexmed Holdings Inc Composicion estabilizada para el tratamiento de psoriasis.
WO2010069519A1 (fr) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Compositions topiques comprenant au moins un ingrédient actif difficilement soluble dans l'eau et des biopolymères, tels que l'acide hyaluronique, présentant une valeur pka située entre 5 et 7
WO2010091274A1 (fr) * 2009-02-06 2010-08-12 Skinvisible Pharmaceuticals, Inc. Composition contenant un composant pharmaceutiquement actif cationique, ses méthodes de fabrication et d'utilisations
EP2745692A1 (fr) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc Formulation antifongique contenant du luliconalzole
MX2011011619A (es) 2009-05-01 2012-02-28 Signal Invest And Man Co Composicion antimicrobiana hidratante.
AU2010274097B2 (en) 2009-07-13 2016-06-16 Medicis Pharmaceutical Corporation Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
GB2479544A (en) * 2010-04-13 2011-10-19 Brands Worldwide Holdings I P Pty Ltd Film forming material to reduce skin irritation due to friction
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US20130324502A1 (en) 2011-02-10 2013-12-05 Moberg Pharma Ab Novel formulations for dermal, transdermal and mucosal use 1
EP2510930A1 (fr) 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanoparticules comportant des semi-esters de poly (méthyl vinyl éther-co-maléique anhydride) et leurs utilisations
DK2800750T3 (en) * 2012-01-03 2017-02-27 Cellceutix Corp Carbocyclic nucleosides and their pharmaceutical use and compositions
CN103191408B (zh) * 2013-04-19 2014-02-12 江苏迪沃生物制品有限公司 一种治疗阴道炎的药物组合物、凝胶剂及其用途
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
CN103301089B (zh) * 2013-07-08 2015-01-07 广东彼迪药业有限公司 一种泛昔洛韦胶囊制剂及其制备方法
WO2015051183A1 (fr) 2013-10-03 2015-04-09 Dow Pharmaceutical Sciences, Inc. Compositions d'éfinaconazole stabilisée
CN103589886A (zh) * 2013-11-17 2014-02-19 湖南金马铝业有限责任公司 一种粉末冶金法生产碳化硅铝基复合材料用粘结剂
US10245257B2 (en) 2013-11-22 2019-04-02 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
CN103933545B (zh) * 2014-05-14 2015-06-17 深圳市红瑞生物科技有限公司 治疗真菌感染的药物及其制备方法
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions
FR3025718A1 (fr) * 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
BR112017016010B1 (pt) * 2015-01-30 2023-02-14 Medrx Co., Ltd Preparação aquosa para uso externo.
CA3016464A1 (fr) 2016-03-08 2017-09-14 Soo-Young Kang Compositions cosmetiques longue duree
CN106074732A (zh) * 2016-07-21 2016-11-09 吕令中 一种治疗牛皮癣的药物及其制备方法
CN108186554B (zh) * 2016-12-08 2022-12-09 海思科制药(眉山)有限公司 一种地奈德乳膏药用组合物及其制备方法
WO2018133010A1 (fr) * 2017-01-19 2018-07-26 广东东阳光药业有限公司 Préparation pour absorption transdermique et son procédé de préparation
CN107261109A (zh) * 2017-07-18 2017-10-20 华若延 一种用于治疗尿布疹的药物组合物及其制备方法
WO2019022249A1 (fr) * 2017-07-28 2019-01-31 国立大学法人九州大学 Composition d'absorption transdermique à libération contrôlée de minoxidil
CN111065665B (zh) 2017-09-13 2023-03-17 生活实验公司 颜色保护剂组合物
AU2018333932B2 (en) 2017-09-13 2024-05-02 Living Proof, Inc. Long lasting cosmetic compositions
CN107823070A (zh) * 2017-12-14 2018-03-23 柳州市柳科科技有限公司 一种护手霜及其制作方法
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CN110200887A (zh) * 2019-07-01 2019-09-06 安徽大学 一种多效生发凝胶及其制备方法
KR102356831B1 (ko) * 2021-04-15 2022-02-08 주식회사 바이오빌리프 용액 형태의 국소 투여용 약학 조성물 및 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2504077B2 (ja) * 1987-10-21 1996-06-05 日産化学工業株式会社 抗真菌剤組成物
JP2635338B2 (ja) * 1987-10-22 1997-07-30 帝國製薬株式会社 保護膜形成型製剤
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6395955B1 (en) * 1998-06-29 2002-05-28 The Procter & Gamble Company Diaper including feces modification agent
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
ATE526917T1 (de) * 2000-02-16 2011-10-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzung
WO2002055023A2 (fr) * 2001-01-09 2002-07-18 Israel Dvoretzky Composition filmogene therapeutique et systeme de traitement pour cette derniere
TW572878B (en) * 2001-05-11 2004-01-21 Fushimi Pharmaceutical Co Ltd Method for production of sugar alcohol
US20040143026A1 (en) * 2002-12-31 2004-07-22 Shah Kishore R. Bioadhesive hydrophilic composition for treatment of mammalian skin
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
WO2007070643A3 (fr) 2008-05-08
EP1959929A4 (fr) 2012-08-15
AU2006326388A1 (en) 2007-06-21
CA2633489A1 (fr) 2007-06-21
CN101378729B (zh) 2013-09-11
WO2007070643A2 (fr) 2007-06-21
CN101378729A (zh) 2009-03-04
JP2009519940A (ja) 2009-05-21
AU2006326388B2 (en) 2013-01-24
EP1959929A2 (fr) 2008-08-27

Similar Documents

Publication Publication Date Title
CA2633489C (fr) Compositions et procedes pour le traitement de conditions dermatologiques
US20070196325A1 (en) Compositions and methods for dermally treating infections
US20120294907A1 (en) Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US8741333B2 (en) Compositions and methods for treating dermatitis or psoriasis
US20120294926A1 (en) Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741332B2 (en) Compositions and methods for dermally treating neuropathic pain
AU2006326018B2 (en) Compositions and methods for dermally treating pain
US20120301517A1 (en) Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20100267678A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
US20070189977A1 (en) Spray-on formulations and methods for dermal delivery of drugs
US20070196293A1 (en) Compositions and methods for treating photo damaged skin
US20140314815A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
US20070196323A1 (en) Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) Compositions and methods for treating alopecia
US20080019927A1 (en) Compositions and methods for dermally treating neuropathy with minoxidil
US20070189978A1 (en) Compositions and methods for dermally treating musculoskeletal pain
EP1959930A2 (fr) Compositions de fluidification et procede pour administrer par voie cutanee des medicaments
AU2006326033A1 (en) Spray-on formulations and methods for dermal delivery of drugs
WO2007100376A2 (fr) compositions et procédés d'administration dermique de médicaments

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161214